Landovitz, R. J., Li, S., Eron, J. J., Grinsztejn, B., Dawood, H., Liu, A. Y., . . . Hendrix, C. W. (2020). Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: A secondary analysis of the HPTN 077 trial. Lancet HIV.
Dyfyniad Arddull ChicagoLandovitz, Raphael J., et al. "Tail-phase Safety, Tolerability, and Pharmacokinetics of Long-acting Injectable Cabotegravir in HIV-uninfected Adults: A Secondary Analysis of the HPTN 077 Trial." Lancet HIV 2020.
Dyfyniad MLALandovitz, Raphael J., et al. "Tail-phase Safety, Tolerability, and Pharmacokinetics of Long-acting Injectable Cabotegravir in HIV-uninfected Adults: A Secondary Analysis of the HPTN 077 Trial." Lancet HIV 2020.
Rhybudd: Mae'n bosib nad yw'r dyfyniadau hyn bob amser yn 100% cywir.